Original Research
Published on 21 Aug 2025
Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study
in Cancer Immunity and Immunotherapy
- 229 views